A LASSO regression model [3] was used to identify a predictive signature from a TCGA training set and four genes [PDZ-binding kinase (PBK), Chromobox 2 (CBX2), CLSPN, and cytoplasmic polyadenylation element-binding protein 3 (CPEB3)], associated with the OS of patients with HCC, were identified [2] . They also established a prognostic risk score and validated the risk score in their HCC patients [2] . The signature of these four genes was an independent prognostic factor particularly for Asian patients with serum α-fetoprotein (AFP) ≥ 20 ng/ml [2] .
PBK has been implicated in the malignancy formation in cancers, including hepatocellular carcinoma [4, 5] . PBK is significantly upregulated in HCC tissue and is associated with increased vascular invasion and shorter survival [5] . PBK enhances the promotion of metastasis of HCC by activating the ETS variant 4 (ETV4)-urokinase plasminogen activator receptor (uPAR) signaling pathway and could be a promising diagnostic biomarker and a potential therapeutic target for HCC metastasis [5] .
CBX2 is highly expressed in human HCC tissues and is associated with poor prognosis in patients with HCC [6] . CBX2 is a crucial component of the polycomb group complex, polycomb repressive complex 1 (PRC1), which is involved in human carcinogenesis [6] .
Claspin, which is encoded by CLSPN, is a checkpoint adapter and DNA replication factor. Claspin degradation is tightly regulated via ubiquitination with multiple ubiquitin ligases and de-ubiquitinases at the proteasome [7] . Claspin contributes to the regulation of checkpoint proficiency and plays a role in the termination of checkpoint-mediated cell cycle arrest. Claspin expression abbreviations and its mutations are clearly associated with both familial and sporadic cancers [7] . Claspin overexpression is one of the markers of radio-resistance in metastasis lung cancer [8] .
Zhou et al. demonstrated that miR-107 may facilitate HCC pathogenesis through the CPEB3/epidermal growth factor receptor (EGFR) axis [9] . Downregulation of CPEB3 promotes human HCC cell proliferation and metastasis [9] . miR-107 was involved in various pathological processes including carcinogenesis, and high expression of miR-107 was observed in HCC tissues compared with non-HCC tissues [9] . Although PBK, CBX2, and CLSPN are located in nucleus, CPEB3 is located in plasma membrane and cytoplasm as well as nucleus. Unfortunately, the study conducted by Yan et al. did not include an analysis of protein expression [2] .
Nonetheless, a novel lncRNAs-miRNAs-mRNAs ceRNA network in HCC based on genome-wide analysis may be useful for finding a new candidate therapeutic decision marker based on the ceRNA network in the prediction of OS of patients with HCC [2] . Further studies will be needed to identify the underlying mechanisms involving these prognostic four genes, miRNAs and lncRNAs. Integrated bioinformatic analysis of mRNA, miRNA, and lncNA expressions, genetic mutations, and epigenetic modifications associated with HCC development will provide important new information in this area. In Asia-Pacific region, more translational research should be performed to reveal which is more accurate way to predict the OS by the four-gene-based signature with or without the biological markers such as AFP, des-γ-carboxy prothrombin (DCP), and glypican-3 ( Fig. 1) [2, 10, 11 ].
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